WD-1603 Carbidopa-Levodopa Extended-Release Tablets

DRUG2 trials

Sponsors

Shanghai WD Pharmaceutical Co., Ltd.

Conditions

Parkinson Disease

Phase 1

Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions

CompletedNCT05128175

Shanghai WD Pharmaceutical Co., Ltd.Parkinson Disease

Start: 2021-10-29End: 2021-12-09Updated: 2026-08-26

Phase 2

A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease

CompletedNCT05036473

Shanghai WD Pharmaceutical Co., Ltd.Parkinson Disease

Start: 2021-11-11End: 2022-12-28Updated: 2026-07-07